Inex, Nova Satra merge to tackle healthcare for Asian women
Add BT as a preferred source
Claudia Chong
DeeperDive is a beta AI feature. Refer to full articles for the facts.
Singapore
SINGAPORE molecular diagnostics groups Inex Innovations Exchange and Nova Satra Dx have merged to form Inex Innovate, in a deal valued at US$72 million and backed by institutional investors including Genting Berhad, Enterprise Singapore and SNS Holdings. SNS Holdings is an investment company owned by Singaporean entrepreneur Sim Giok Lak and his family.
The combined company will be focused on addressing the unmet need for faster and more accurate diagnostics testing and precision healthcare for Asian women.
Copyright SPH Media. All rights reserved.
TRENDING NOW
China pips the US if Asean is forced to choose, but analysts warn against reading it like a sports result
Beijing’s calculated silence on the Iran war
Shelving S$5 billion office redevelopment plan proved ‘wise’ as geopolitical risks mount: OCBC chairman
Vietnam formalises new state leadership, redefining ‘four pillars’ power balance
